- Report
- June 2022
- 120 Pages
Global
From €4201EUR$4,750USD£3,622GBP
- Report
- January 2022
- 110 Pages
Global
From €4201EUR$4,750USD£3,622GBP
- Report
- February 2024
- 110 Pages
Global
From €4201EUR$4,750USD£3,622GBP
- Report
- August 2024
- 111 Pages
From €3052EUR$3,450USD£2,631GBP
- Report
- April 2024
- 65 Pages
China
From €3052EUR$3,450USD£2,631GBP
- Report
- April 2024
- 158 Pages
Global
From €3936EUR$4,450USD£3,394GBP
- Report
- March 2022
- 279 Pages
Global
From €3936EUR$4,450USD£3,394GBP
- Report
- March 2021
Global
From €3936EUR$4,450USD£3,394GBP
- Report
- April 2024
- 125 Pages
Global
From €2795EUR$3,160USD£2,410GBP
€3494EUR$3,950USD£3,012GBP
- Report
- February 2024
- 140 Pages
Global
From €3007EUR$3,400USD£2,593GBP
€3759EUR$4,250USD£3,241GBP
- Report
- January 2024
- 143 Pages
Global
From €3007EUR$3,400USD£2,593GBP
€3759EUR$4,250USD£3,241GBP
- Report
- February 2024
- 114 Pages
Global
From €4201EUR$4,750USD£3,622GBP
- Report
- February 2024
- 112 Pages
Global
From €4201EUR$4,750USD£3,622GBP
- Report
- February 2024
- 112 Pages
Global
From €4201EUR$4,750USD£3,622GBP
- Report
- January 2022
- 115 Pages
Global
From €4201EUR$4,750USD£3,622GBP
- Report
- August 2024
- 145 Pages
Global
From €2211EUR$2,500USD£1,906GBP
- Report
- July 2024
- 153 Pages
Global
From €2211EUR$2,500USD£1,906GBP
- Report
- May 2024
- 175 Pages
Global
From €2211EUR$2,500USD£1,906GBP
- Report
- February 2024
- 170 Pages
Global
From €2211EUR$2,500USD£1,906GBP
- Report
- May 2024
- 160 Pages
Global
From €4395EUR$4,969USD£3,789GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more